Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A Systematic Review and Meta-Analysis of Cohort Studies

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Circulation. Cardiovascular Quality and Outcomes

• Publication date

  2012-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCOUTCOMES.112.966903PMID 23300267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

  2012cited by this paper
• Erectile dysfunction is predictive of all‐cause mortality in patients with prostate cancer treated with permanent interstitial brachytherapy

  2012cited by this paper
• Erectile dysfunction is not independently associated with cardiovascular death: data from the vitamins and lifestyle (VITAL) study.

  2012cited by this paper
• The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease.

  2012cited by this paper
• Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies.

  2011cited by this paper
• Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction.

  2011cited by this paper
• Increased risk of stroke among men with erectile dysfunction: a nationwide population-based study.

  2011cited by this paper
• The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis.

  2011cited by this paper
• Distribution of 10-Year and Lifetime Predicted Risks for Cardiovascular Disease in US Adults: Findings From the National Health and Nutrition Examination Survey 2003 to 2006

  2010cited by this paper
• Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?

  2010cited by this paper
• Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial.

  2010cited by this paper
• Sexual activity, erectile dysfunction, and incident cardiovascular events.

  2010cited by this paper
• Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction.

  2010cited by this paper
• Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndrome

  2010cited by this paper
• Is erectile dysfunction a predictor of cardiovascular events or stroke? A prospective study using a validated questionnaire

  2010cited by this paper
• Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONT

  2010cited by this paper
• Erectile dysfunction and risk of clinical cardiovascular events: a meta-analysis of seven cohort studies.

  2010cited by this paper
• Erectile dysfunction and coronary artery disease prediction: evidence‐based guidance and consensus

  2010cited by this paper
• The impact of preoperative erectile dysfunction on survival after radical prostatectomy

  2010cited by this paper
• Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.

  2010cited by this paper
• Erectile dysfunction as a predictor for subsequent atherosclerotic cardiovascular events: findings from a linked-data study.

  2010cited by this paper
• Peripheral vascular disease and erectile dysfunction as predictors of mortality in heart failure patients.

  2009cited by this paper
• Erectile dysfunction and mortality.

  2009cited by this paper
• PDE5 inhibitors in non-urological conditions.

  2009cited by this paper
• Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement.

  2009cited by this paper
• A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

  2009cited by this paper
• Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.

  2008cited by this paper
• Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study

  2008cited by this paper
• Erectile dysfunction predicts coronary heart disease in type 2 diabetes.

  2008cited by this paper
• The triad: erectile dysfunction--endothelial dysfunction--cardiovascular disease.

  2008cited by this paper
• Testosterone making an entry into the cardiometabolic world.

  2007cited by this paper
• Cardiovascular risk among men seeking help for erectile dysfunction.

  2006cited by this paper
• Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial.

  2006cited by this paper
• Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease.

  2006cited by this paper
• Comorbid conditions in men with ED before and after ED diagnosis: a retrospective database study

  2006cited by this paper
• Erectile dysfunction and subsequent cardiovascular disease.

  2005cited by this paper
• Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study.

  2005cited by this paper
• Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?

  2005cited by this paper
• Coronary artery risk factors in patients with erectile dysfunction.

  2004cited by this paper
• Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Is erectile dysfunction predictive of peripheral vascular disease?

  2003cited by this paper
• Interaction revisited: the difference between two estimates

  2003cited by this paper
• Meta-analysis of observational studies in epidemiology - A proposal for reporting

  2000cited by this paper
• Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.

  2000cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

  2000cited by this paper
• The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

  1999cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study.

  1994cited by this paper
• The file drawer problem and tolerance for null results

  1979cited by this paper
• The Environment and Disease: Association or Causation?

  1965cited by this paper

• Neutrophil percentage-to-albumin ratio as a novel hematologic biomarker for predicting arteriogenic erectile dysfunction

  2026cites this paper
• Penile Hemodynamic Patterns Highlighting the Impact of Diabetes in Young Men With Erectile Dysfunction.

  2026cites this paper
• Association of erectile dysfunction with all-cause and cardiovascular mortality in US men: findings from NHANES 2001-2004 with 16-year follow-up.

  2025cites this paper
• Advances in stem cell therapy for erectile dysfunction: preclinical evidence and emerging therapeutic approaches

  2025cites this paper
• Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications

  2025cites this paper
• Evaluation of magnetic stimulation as a non-invasive technique in treating different causes of erectile dysfunction: a prospective cohort study

  2025cites this paper
• Associations of arterial stiffness onset age with type 2 diabetes risk: a large-scale Chinese cohort study

  2025cites this paper
• Next-generation pharmaceuticals: the rise of sildenafil citrate ODF for the treatment of men with erectile dysfunction

  2025cites this paper
• Erectile dysfunction increases the risk of stroke: evidence from NHANES and Mendelian randomization analysis

  2025cites this paper
• Erectile dysfunction and cardiovascular-kidney-metabolic syndrome: Insights from the all of us research program

  2025cites this paper
• A holistic view of SGLT2 inhibitors: From cardio-renal management to cognitive and andrological aspects.

  2025cites this paper
• Systematic Monitoring of the Cardiovascular Risk in the Primary Care Approved for the Slovak Republic

  2025cites this paper
• Reassessing cardiovascular risk stratification in men with erectile dysfunction.

  2024cites this paper
• Post stroke sexual dysfunction - a current review

  2024cites this paper
• Exploring the bidirectional link between erectile dysfunction and 10-year cardiovascular risk in men with diabetes and hypertension

  2024cites this paper
• A Study of the Relationship Between Objective Tests to Diagnose Erectile Dysfunction and Markers of Cardiovascular Disease

  2024cites this paper
• Guilingji capsules enhances erectile function by promoting testosterone-dependent angiogenesis in the corpus cavernosum

  2024cites this paper
• Associations of movement behaviours and dietary intake with arterial stiffness: results from the ORISCAV-LUX 2 cross-sectional study

  2024cites this paper
• Risk of Death in Patients With Coronary Artery Disease Taking Nitrates and Phosphodiesterase-5 Inhibitors.

  2024cites this paper
• Erectile dysfunction as a holistic indicator of well-being: a narrative review.

  2024cites this paper
• Risk of major adverse cardiovascular events in rural vs urban settings among patients with erectile dysfunction: a propensity-weighted retrospective cohort study of 430 621 men.

  2024cites this paper
• Mechanisms of erectile dysfunction induced by aging: A comprehensive review

  2024cites this paper
• Association of erectile dysfunction and peripheral arterial disease in NHANES 2001-2004: a cross-sectional study

  2024cites this paper
• Cardiovascular Risk Assessment Scores: A Narrative Review

  2024cites this paper
• Study on serum metabolomics characteristics of obese patients with erectile dysfunction

  2024cites this paper
• 2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part II.

  2024cites this paper
• Circulating miRNA-21 is an innovative biomarker for cardiovascular events in erectile dysfunction patients

  2024cites this paper
• Association between erectile dysfunction and the prevalence and prognosis of hyperglycemia in adults in the USA based on NHANES 2001–2004

  2024cites this paper
• An Acupuncture Protocol for the Treatment of Erectile Dysfunction: A Delphi Process

  2024cites this paper
• Underlying disease risk among patients with fatigue: a population-based cohort study in primary care

  2024cites this paper
• Arterial stiffness and the non-dipping pattern in type 1 diabetes males with and without erectile dysfunction

  2023cites this paper
• Hormones and Aging: An Endocrine Society Scientific Statement.

  2023cites this paper
• Ranking of cardiovascular risk factors in Romania- regional epidemiological approach

  2023cites this paper
• Characteristics of Gut Microbiota in Patients with Erectile Dysfunction: A Chinese Pilot Study

  2023cites this paper
• Improvement in Endothelial Function in men taking phosphordiesterase type 5 inhibitors for erectile dysfunction.

  2023cites this paper
• Atherosclerosis of the iliac arteries for the prediction of erectile dysfunction and epistaxis in men undergoing abdominal CT scan

  2023cites this paper
• Dysfonction érectile d’origine vasculaire

  2023cites this paper
• Effects of obesity‐related anthropometric indices and body composition on erectile dysfunction mediated by coronary artery disease: A Mendelian randomization study

  2023cites this paper
• Die polyvaskuläre Erkrankung – eine Übersicht über die Datenlage und Managementstrategien

  2022cites this paper
• Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica

  2022cites this paper
• Erectile dysfunction, phosphodiesterase-5 inhibitor use and risk of cardiovascular disease and mortality in people with diabetes: A systematic review and meta-analysis.

  2022cites this paper
• Enfermedad cardiovascular aterosclerótica y sexualidad

  2022cites this paper
• Tip of the iceberg: erectile dysfunction and COVID-19

  2022cites this paper
• Exercise, Erectile Dysfunction and Co-Morbidities: “The Good, the Bad and the Ugly”

  2022cites this paper
• Erectile dysfunction predicts mortality in middle-aged and older men independent of their sex steroid status.

  2022cites this paper
• A multi-faceted intervention to improve screening of erectile dysfunction for men with diabetes mellitus in public health clinics: A pilot study.

  2022cites this paper
• The prevalence and severity of mental health problems and sexual dysfunction in hemodialysis patients before and during the COVID‐19 pandemic

  2022cites this paper
• Urological Society of Australia and New Zealand (USANZ) and Australasian Chapter of Sexual Health Medicine (AChSHM) for the Royal Australasian College of Physicians (RACP) clinical guidelines on the management of erectile dysfunction

  2022cites this paper
• Long-term high-dose l-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial

  2022cites this paper
• Risk of osteoporosis in patients with erectile dysfunction

  2021cites this paper
• Impact of Allogeneic Stem Cell Transplantation on Testicular and Sexual Function.

  2021cites this paper
• Erectile Dysfunction in Diabetic Patients: From Etiology to Management

  2021cites this paper
• Intracavernous injection of stem cell-derived bioactive molecules for erectile dysfunction—a pilot phase non-randomized controlled trial

  2021cites this paper
• Are sex disparities in COVID-19 a predictable outcome of failing men’s health provision?

  2021cites this paper
• Factores de riesgo cardiovascular

  2021cites this paper
• Patients with periodontitis and erectile dysfunction suffer a greater incidence of major adverse cardiovascular events: a prospective study in Spanish population.

  2021cites this paper
• Canadian Urological Association guideline: Erectile dysfunction.

  2021cites this paper
• Significant Increase of Erectile Dysfunction in Men With Post-stroke: A Comprehensive Review

  2021cites this paper
• Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

  2021cites this paper
• Metabolic Syndrome and Reproduction

  2021cites this paper
• Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs

  2021cites this paper
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

  2021cites this paper
• 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

  2021cites this paper
• Erectile dysfunction: is the NHS men's health friendly?

  2020cites this paper
• Survival of Patients on Hemodialysis with Erectile Dysfunction

  2020cites this paper
• Men’s Health 2020

  2020cites this paper
• Analysis of Arterial Stiffness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience

  2020cites this paper
• Penile Ultrasound

  2020cites this paper
• Рискове и предизвикателства пред защитата на данните в ерата на COVID - 19

  2020cites this paper
• Analysis of Arterial Sti ff ness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience

  2020cites this paper
• Erectile Dysfunction in Peripheral Vascular Disease: Endovascular Revascularization as a Potential Therapeutic Target

  2020cites this paper
• Erectile dysfunction as a cardiovascular risk factor: time to step up?.

  2020cites this paper
• People smoke for nicotine, but lose sexual and reproductive health for tar: a narrative review on the effect of cigarette smoking on male sexuality and reproduction

  2020cites this paper
• Relation Between Severity of Coronary Artery Disease and Aorto-Ilio-Pudendal Artery Disease in Patients With Ischemic Heart Disease-Associated Vascular Erectile Dysfunction.

  2020cites this paper
• Change in Frequency and Predictors of Erectile Dysfunction With Changes in the International Index of Erectile Function-Erectile Function Domain Score in Patients With ST-Elevation Myocardial Infarction: A Prospective, Longitudinal Study.

  2020cites this paper
• Nonalcoholic Fatty Liver Disease, Male Sexual Dysfunction, and Infertility: Common Links, Common Problems.

  2020cites this paper
• Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?

  2020cites this paper
• Stiffness of the Central Corpus Cavernosum on Shear-Wave Elastography Is Inversely Correlated with the Penile Rigidity Score in Patients with Erectile Dysfunction

  2020cites this paper
• Update of the position paper on arterial hypertension and erectile dysfunction.

  2020cites this paper
• A cross-sectional observation to investigate subsequent cardiovascular diseases in Taiwanese men with erectile dysfunction

  2020cites this paper
• Restoration of erectile function by suppression of corporal apoptosis and oxidative stress with losartan in aged rats with erectile dysfunction

  2020cites this paper
• Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management

  2020cites this paper
• Red blood cell distribution width values in erectile dysfunction.

  2020cites this paper
• SHORT-TERM EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY ON RISK PREDICTORS FOR ARTERIOSCLEROSIS AMONG MEN WITH LATE-ONSET HYPOGONADISM: A CASE–CONTROL STUDY

  2020cites this paper
• Do phosphodiesterase-5 inhibitors have a cardioprotective effect?

  2020cites this paper
• Microvascular complications of type 2 diabetes mellitus.

  2020cites this paper
• Prevalence of Erectile Dysfunction in Patients With End-Stage Renal Disease: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses

  2020cites this paper
• Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management

  2020cites this paper
• Erectile dysfunction and cardiovascular risk: a review of current findings

  2020cites this paper
• The association between erectile dysfunction and CVD

  2019cites this paper
• Age at First Presentation for Erectile Dysfunction: Analysis of Changes over a 12-yr Period.

  2019cites this paper
• Baseline atrial fibrillation is a risk factor for erectile dysfunction: Systemic review and meta-analysis

  2019cites this paper
• [Erectile dysfunction in Parkinson's disease].

  2019cites this paper
• An update on heart disease risk associated with testosterone boosting medications

  2019cites this paper
• Physical Activity, Fitness, and Sexual Dysfunction

  2019cites this paper
• Erectile Dysfunction Predicts Cardiovascular Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis.

  2019cites this paper
• Serum Tumor Necrosis Factor-α (TNF-α) with Erectile Dysfunction in Psoriatic Patients

  2019cites this paper
• Farmakoterapie erektilní dysfunkce – kde jsme a kam směřujeme

  2019cites this paper
• Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention?

  2019cites this paper